A phase 1b study of SHR-2017, a RANKL/NGF targeted antibody, in patients (pts) with breast cancer bone metastasis.

Authors: Xu Liang, Yaxin Liu, Hanfang Jiang, Guohong Song, Yun Zhang, Qian Zhao, Yuanyuan Huang, Tengrui Yin, Gang Cheng, Lingling Xu, Huiping Li

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.12059

Source: Full article


Abstract

12059